high linear energy transfer radionuclide 211at certain therapeutic applications path length achieving homogeneous tracer distribution critical hyperthermia enhance therapeutic efficacy endoradiotherapy improve tracer distribution study investigated hyperthermia increased cytotoxicity monoclonal antibody mab tumour spheroids radius approximately NUMBER microm greater range 211at hyperthermia NUMBER h NUMBER degrees c used treatment resulted regrowth delay radiolabelled chimeric mab 81c6 reactive extracellular matrix antigen tenascin added spheroids grown mg human glioma cell line activity concentrations ranging NUMBER NUMBER kbq significant regrowth delay observed NUMBER NUMBER kbq untreated spheroids groups receiving hyperthermia increase cytotoxicity seen compared normothermic controls activity concentration results autoradiographs indicate hyperthermia NUMBER degrees c NUMBER h significant effect uptake distribution antitenascin mab mg spheroids alpha particle emitting astatine NUMBER NUMBER NUMBER microm alpha particles alpha particle 211at labelled alpha particles d NUMBER ml NUMBER ml NUMBER hyperthermia treated d NUMBER